Resources

Hopes for a vaccine to guard against juvenile diabetes have been boosted with the launch of a ground-breaking clinical trial in Melbourne.

Initial treatment with rosiglitazone slowed the progression to monotherapy failure more effectively than either metformin or glyburide.

Which treatment therapy was more effective?

The obesity epidemic is leading more people to develop type 1 and type 2 disease.

Department of Health of NY City, shows Trans Fats the Door, after voting unanimously to ban the substance from the city’s restaurants.

Drinking a protein hydrolysate/leucine beverage with meals reduces the prevalence of hyperglycemia in patients with type 2 diabetes, according to a new report.

Only 45% women in the cohort underwent postpartum glucose testing, as recommended.

New study results show patients with an HbA1c level of at least 8.5 when they started taking Acomplia saw their their blood sugar level decrease 1.9 points compared to 0.7 points in patients on a placebo.

Data Support JANUMET™, an Investigational Combination Therapy of Sitagliptin Phosphate Plus Metformin for Type 2 Diabetes

Skin autofluorescence, as a measure of the accumulation of advanced glycation end products (AGEs) in tissue, may serve as an indicator of vascular damage in patients with type 2 diabetes, according to a new report.